AIC
PFE icon

Ambs Investment Counsel’s Pfizer PFE Stock Holding History

Ambs Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$716K Hold
26,260
– – 0.43% 48
2013
Q2 		$698K Buy
+26,260
New +$726K 0.32% 45

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ambs Investment Counsel's PFE Position: Q3 2013 in Review

Ambs Investment Counsel held its Pfizer (PFE) position steady in Q3 2013 at 26,260 shares worth $716K. The position accounts for 0.43% of the portfolio, ranked #48.

Ambs Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 2 quarters since. 1,605 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Ambs Investment Counsel held 26,260 shares of Pfizer worth $716K as of Q3 2013.
  • Ambs Investment Counsel left its Pfizer share count unchanged in Q3 2013.
  • Pfizer made up 0.43% of Ambs Investment Counsel's portfolio in Q3 2013, its #48 holding.
  • Ambs Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 2 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Ambs Investment Counsel's 13F filing for Q3 2013, filed 4 Nov 2013.